| Home | E-Submission | Sitemap | Editorial Office
top_img
Current Issue > Browse Articles > Current Issue



Reviews
265 Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
Edward Wolfgang Lee, Sarah Khan
Clin Mol Hepatol.2017;23(4):265-272.   Published online November 8, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0111
                                 Cited By 2
273 Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Imane El Dika, Ghassan K. Abou-Alfa
Clin Mol Hepatol.2017;23(4):273-279.   Published online November 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0108
                                 Cited By 1
280 Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin
Clin Mol Hepatol.2017;23(4):280-289.   Published online September 15, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0037
                              
290 Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
Dong Ho Lee
Clin Mol Hepatol.2017;23(4):290-301.   Published online October 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0042
                              
302 Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo, Haeryoung Kim
Clin Mol Hepatol.2017;23(4):302-307.   Published online December 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0078
                                 Cited By 1
Editorials
308 Use of sofosbuvir in chronic kidney disease: Is it necessary?
Tae Seop Lim, Sang Hoon Ahn
Clin Mol Hepatol.2017;23(4):308-310.   Published online September 26, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0109
                                 Cited By 1
311 Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
Joon Yeul Nam, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(4):311-313.   Published online December 4, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0069
                              
314 Lamivudine: fading into the mists of time
Jonggi Choi, Young-Suk Lim
Clin Mol Hepatol.2017;23(4):314-315.   Published online November 28, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0110
                              
Original Articles
316 Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
Clin Mol Hepatol.2017;23(4):316-322.   Published online August 22, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0087
                                 Cited By 1
323 Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol.2017;23(4):323-330.   Published online September 5, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0005
                                 Cited By 2
331 Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
Clin Mol Hepatol.2017;23(4):331-339.   Published online September 26, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0040
                              
Case Report
340 Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol.2017;23(4):340-346.   Published online June 20, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0070
                              
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.